Journal
SCHIZOPHRENIA RESEARCH
Volume 55, Issue 1-2, Pages 197-204Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/S0920-9964(01)00180-3
Keywords
dopamine; color vision; hue discrimination; tritan (blue-hue); schizophrenia
Categories
Funding
- NIMH NIH HHS [R01-MH40799] Funding Source: Medline
Ask authors/readers for more resources
Neuropsychiatric conditions that involve dopaminergic depletion have been associated with color discrimination deficits along the blue-hue (tritan, or short-wavelength-sensitive) axis. Because dopamine dysregulation may be a major factor in schizophrenia, we investigated color vision in this disorder. The performance of males with schizophrenia (SZ, n = 16) and normal male control subjects (CS, n = 14) was evaluated on five measures of color discrimination. SZ made more hue discrimination errors than CS, but no pattern emerged regarding a hue-specific axis of deficit. Dosage of anti-psychotic medication was not correlated with performance on hue discrimination. These results suggest that in medicated patients with schizophrenia, the dopaminergic disturbance, which may involve system hyperactivity, does not produce tritan-specific color deficits that have been observed in disorders involving dopaminergic hypoactivity. (C) 2002 Elsevier Science B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available